BromSite FDA Approval History
FDA Approved: Yes (First approved April 8, 2016)
Brand name: BromSite
Generic name: bromfenac
Dosage form: Ophthalmic Solution
Company: Sun Pharmaceutical Industries Inc.
Treatment for: Postoperative Ocular Inflammation
BromSite (bromfenac) is a low dose nonsteroidal anti-inflammatory drug (NSAID) ophthalmic solution for the treatment of inflammation and prevention of pain in patients undergoing cataract surgery.
Development timeline for BromSite
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.